Clinical evidence for immune cell-based therapy for head and neck cancer: A systematic review and meta-analysis.

Crit Rev Oncol HematolJul 11, 2026 (epub)
Clinical ResearchOncology (Medical)

Dong-Hyeon Jo, Jongbok Lee, Min-Su Kim

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated immune cell-based therapy (ICT) in head and neck squamous cell carcinoma (HNSCC) across 30 studies involving 953 patients. The analysis found no significant benefits in tumor response or survival from ICT in randomized trials, particularly in nasopharyngeal carcinoma (NPC). The only nonrandomized trial in non-nasopharyngeal HNSCC suggested longer median survival, but lacked statistical significance.

Key findings

  • Pooled complete response rate was 11% across 26 single-arm trials.
  • Objective response rate was 22%, and disease control rate was 56%.
  • Adverse events ≥ grade 3 occurred in 12% of patients.
  • Randomized trials in NPC showed no significant ICT benefits for survival outcomes.

Why it matters

The findings highlight the limited efficacy of current ICT approaches in HNSCC, particularly in non-nasopharyngeal cases. Clinicians should be aware of the lack of robust evidence supporting ICT in this population, emphasizing the need for further research.

Source

Published in Crit Rev Oncol Hematol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.